CITADEL ADVISORS LLC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
CITADEL ADVISORS LLC | 5,635,132 3.000% |
-4,094,620 (-42.08%) |
Filing |
| 2023-07-03 4:02 pm Purchase |
2023-06-23 | 13G | Nektar Therapeutics NKTR |
CITADEL ADVISORS LLC | 9,729,752 5.100% |
9,729,752 (New Position) |
Filing |